Jiun-Tsai Lin Selected Research

Adenine

12/2021	The Cell Protective Effect of Adenine on Hypoxia-Reoxygenation Injury through PPAR Delta Activation.
8/2021	Adenine Inhibits the Invasive Potential of DLD-1 Human Colorectal Cancer Cell via the AMPK/FAK Axis.
1/2021	Modulation of adenine phosphoribosyltransferase-mediated salvage pathway to accelerate diabetic wound healing.
1/2020	Adenine inhibits growth of hepatocellular carcinoma cells via AMPK-mediated S phase arrest and apoptotic cascade.
1/2018	Adenine accelerated the diabetic wound healing by PPAR delta and angiogenic regulation.
11/2017	Adenine causes cell cycle arrest and autophagy of chronic myelogenous leukemia K562 cells via AMP-activated protein kinase signaling.
4/2015	Identification of adenine modulating AMPK activation in NIH/3T3 cells by proteomic approach.
1/2015	Activation of AMP-Activated Protein Kinase by Adenine Alleviates TNF-Alpha-Induced Inflammation in Human Umbilical Vein Endothelial Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiun-Tsai Lin Research Topics

Disease

2	Neoplasms (Cancer) 08/2021 - 01/2020
2	Wounds and Injuries (Trauma) 01/2021 - 01/2018
2	Inflammation (Inflammations) 01/2015 - 01/2014
2	Huntington Disease (Huntington's Disease) 03/2013 - 01/2011
1	Ischemia 12/2021
1	Hypoxia (Hypoxemia) 12/2021
1	Colorectal Neoplasms (Colorectal Cancer) 08/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Sepsis (Septicemia) 12/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2015
1	Lymphoma (Lymphomas) 09/2015
1	Insulin Resistance 04/2015
1	Hyperglycemia 04/2015
1	Ulcer 09/2014
1	Neuroinflammatory Diseases 01/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2011

Drug/Important Bio-Agent (IBA)

8	Adenine FDA LinkGeneric 12/2021 - 01/2015
3	AMP-Activated Protein KinasesIBA 11/2017 - 09/2014
2	Adenosine Triphosphate (ATP)IBA 12/2021 - 01/2021
1	Free RadicalsIBA 12/2021
1	PPAR deltaIBA 12/2021
1	NucleotidesIBA 01/2021
1	CytokinesIBA 12/2019
1	Ointments (Pastes)IBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	Protein Kinases (Protein Kinase)IBA 09/2015
1	purineIBA 09/2015
1	Proteins (Proteins, Gene)FDA Link 09/2015
1	Glucose (Dextrose)FDA LinkGeneric 04/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	ENERGI-F704IBA 01/2014
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 03/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2013
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2011
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2011
1	Serotonin ReceptorsIBA 01/2011
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2011

Therapy/Procedure

2	Therapeutics 11/2017 - 09/2014